Quarterly report pursuant to Section 13 or 15(d)

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.10.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Apr. 02, 2018
Jun. 07, 2017
Mar. 21, 2018
Sep. 25, 2017
Jul. 25, 2017
May 22, 2017
Apr. 21, 2017
Jun. 30, 2018
Jan. 10, 2017
Convertible note               $ 25,000  
Denver Savings Bank [Member]                  
Convertible promissory notes principal amount         $ 1,500,000        
Interest rate         4.50%        
Debt instrument maturity term         3 years        
Loan origination fee         $ 300,000        
Ms. Greta Lang [Member]                  
Warrant to purchase of common stock shares 82,500   82,500            
Convertible note $ 25,000   $ 275,000            
Terms of conversion feature, description

At any time prior to the maturity date, the note is convertible into shares of common stock of the Company at a price per share equal to (i) 90% of the of the closing price of the common stock for 20 consecutive trading days immediately preceding such conversion (ii) Floor Conversion Price at $0.60 per share.

 
At any time prior to the maturity date, the note is convertible into shares of common stock of the Company at a price per share equal to (i) 90% of the of the closing price of the common stock for 20 consecutive trading days immediately preceding such conversion (ii) Floor Conversion Price at $0.60 per share.
           
Description of interest rate computation
Interest will accrue at 7.5% computed on a 365-day basis. Interest is payable upon conversion of the convertible note at the applicable conversion price.
 
Interest will accrue at 7.5% computed on a 365-day basis. Interest is payable upon conversion of the convertible note at the applicable conversion price.
           
Interest rate 7.50%   7.50%            
K4 Enterprise, LLC [Member]                  
Loan payable               $ 1,082,652  
Mr. Arthur [Member]                  
Warrant to purchase of common stock shares       10,500          
Exercise price per share       $ 1.30          
Convertible note       $ 35,000          
Terms of conversion feature, description      

At any time prior to the maturity date, the note is convertible into shares of common stock of the Company at a price per share equal to 90% of the closing bid price of the common stock during the 20 consecutive trading days immediately preceding such conversion and the Floor Conversion price shall mean $0.60 per share

         
Description of interest rate computation      

Interest will accrue at 7.5% computed on a 365-day basis. Interest is payable upon conversion of the convertible note at the applicable conversion price.

         
Interest rate       7.50%          
Mr. Arthur [Member] | Royality Agreement [Member]                  
Royalty description              

Aggregate of 5% of net revenue.

 
Term description              

In connection with the issuance of the note, Caretta Therapeutics, LLC (a subsidiary of the Company) entered into a royalty agreement with Mr. Arthur pursuant to which Mr. Arthur will receive a pro rata share of a royalty during the years ended 2017, 2018, 2019 and 2020 of the Company’s subsidiary Caretta Therapeutics, LLC as follows:

 
Dr. Beetler [Member]                  
Warrant to purchase of common stock shares   82,500         7,500    
Exercise price per share   $ 1.30              
Convertible note   $ 250,000         $ 25,000    
Terms of conversion feature, description  

At any time prior to the maturity date, the note is convertible into shares of common stock of the Company at a price per share equal to 90% of the closing bid price of the common stock during the 20 consecutive trading days immediately preceding such conversion and the Floor Conversion price as described in the table below

  

Conversion Date (by calendar Quarter)   Floor Conversion Price  
2017 Q2   $ 0.60  
2017 Q3   $ 0.70  
2017 Q4   $ 0.85  
2018 Q1   $ 1.00  
Each Subsequent Quarter  

Increase $0.10

per Quarter

 
       

At any time prior to the maturity date, the note is convertible into shares of common stock of the Company at a price per share equal to 90% of the closing bid price of the common stock during the 20 consecutive trading days immediately preceding such conversion.

   
Description of interest rate computation  

Interest will accrue at 7.5% computed on a 365-day basis. Interest is payable upon conversion of the convertible note at the applicable conversion price.

       

Interest will accrue at 7.5% computed on a 365-day basis. Interest is payable upon conversion of the convertible note at the applicable conversion price.

   
Interest rate   7.50%         7.50%    
Cristopher Grunewald [Member]                  
Warrant to purchase of common stock shares           500,000      
Exercise price per share           $ 1.25      
Warrants Term           3 years      
Cancellation of common stock shares           1,618,627      
Cristopher Grunewald [Member] | Employment agreement [Member]                  
Annual compensation payable under agreement                 $ 180,000
Ms. Lang [Member] | Royality Agreement [Member]                  
Term description              

In connection with the issuance of the note, Caretta Therapeutics, LLC (a subsidiary of the Company) entered into a royalty agreement with Ms. Lang pursuant to which Ms. Lang will receive a pro rata share of a royalty during the years ended 2018 through September 30, 2024 of the Company’s subsidiary Caretta Therapeutics, LLC with a maximum royalty amount of 9 times the principal amount of the convertible note.